Zoekresultaten - 4 results

Tackling cervical cancer in Europe amidst the COVID-19 pandemic.

least 90% of girls by age 15 years, by offering screening at least twice in a lifetime to 70% or more of the target age populations and treat more than 90% of women with screen-detected lesions. Recently, ...

The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer

the working age population (16–64 years). There is a strong need to assess and understand their reintegration on the labour market, which underlines and ensures their social integration and quality of ...

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.

those associated with vaccine HPV types and any cervical precancer. Exposure groups were: women aged: 15-26 or 24-45 years being initially negative for high-risk HPV (hrHPV) or negative for the vaccine ...

QR code

QR code for this page URL